5701 - 5750 of 7665 Results
Title
Year
- Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study2017RESTRICTEDTitle: Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental StudyJournal Name: Health Services ResearchPublisher: WileyVol: 53Issue #: S1Start Page: 2735End Page: 2757Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/1475-6773.12744Best OA location URL: https://europepmc.org/articles/pmc6056595?pdf=renderCitation Count: 23
-
RESTRICTEDTitle: Ligand Dependent Switch from RXR Homo- to RXR-NURR1 HeterodimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 9Start Page: 2065End Page: 2077Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.7b00216Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00216Citation Count: 19
- A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations2017RESTRICTEDTitle: A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerationsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 8Start Page: 1117End Page: 1130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27090Best OA location URL: https://europepmc.org/articles/pmc5638072?pdf=renderCitation Count: 55
-
RESTRICTEDTitle: Striatal cholinergic interneurons and Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 47Issue #: 10Start Page: 1148End Page: 1158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13638Best OA location URL: https://europepmc.org/articles/pmc6074051?pdf=renderCitation Count: 70
- Tissue-specific network-based genome wide study of amygdala imaging phenotypes to identify functional interaction modules2017RESTRICTEDTitle: Tissue-specific network-based genome wide study of amygdala imaging phenotypes to identify functional interaction modulesJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 33Issue #: 20Start Page: 3250End Page: 3257Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btx344Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/33/20/3250/28016045/btx344.pdfCitation Count: 22
- Comparison of Cortical and Subcortical Measurements in Normal Older Adults across Databases and Software Packages2017RESTRICTEDTitle: Comparison of Cortical and Subcortical Measurements in Normal Older Adults across Databases and Software PackagesJournal Name: Journal of Alzheimer's Disease ReportsPublisher: IOS PressVol: 1Issue #: 1Start Page: 59End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/adr-170008Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease-reports/adr170008?id=journal-of-alzheimers-disease-reports%2Fadr170008Citation Count: 7
- Mentally stimulating activities associate with better cognitive performance in Parkinson disease2017RESTRICTEDTitle: Mentally stimulating activities associate with better cognitive performance in Parkinson diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 124Issue #: 10Start Page: 1205End Page: 1212Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-017-1761-4Best OA location URL: https://europepmc.org/articles/pmc5693756?pdf=renderCitation Count: 5
- O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease2017RESTRICTEDTitle: O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s diseaseJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-017-0311-1Best OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-017-0311-1Citation Count: 70
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease2017RESTRICTEDTitle: Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 49Issue #: 9Start Page: 1373End Page: 1384Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ng.3916Best OA location URL: https://europepmc.org/articles/pmc5669039?pdf=renderCitation Count: 786
-
RESTRICTEDTitle: Predictors of weight loss in early treated Parkinson’s disease from the NET-PD LS-1 cohortJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 264Issue #: 8Start Page: 1746End Page: 1753Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-017-8562-4Best OA location URL: https://europepmc.org/articles/pmc5789795?pdf=renderCitation Count: 34
- The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions2017RESTRICTEDTitle: The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactionsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-05760-9Best OA location URL: https://www.nature.com/articles/s41598-017-05760-9.pdfCitation Count: 47
-
RESTRICTEDTitle: Progress toward an integrated understanding of Parkinson’s diseaseJournal Name: F1000ResearchPublisher: F1000 Research LtdVol: 6Issue #:Start Page: 1121End Page: 1121Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.12688/f1000research.11820.1Best OA location URL: https://f1000research.com/articles/6-1121/v1/pdfCitation Count: 23
-
RESTRICTEDTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 84
- DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation2017RESTRICTEDTitle: DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimationJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 7Start Page: e0180467End Page: e0180467Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0180467Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0180467&type=printableCitation Count: 28
-
RESTRICTEDTitle: Fine-Tuning ER Stress Signal Transducers to Treat Amyotrophic Lateral SclerosisJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2017.00216Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2017.00216/pdfCitation Count: 19
- Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease2017RESTRICTEDTitle: Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's diseaseJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 8Start Page: 632End Page: 642Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nsmb.3433Best OA location URL: https://www.nature.com/articles/nsmb.3433.pdfCitation Count: 141
-
RESTRICTEDTitle: Connectivity Predicts deep brain stimulation outcome in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 1Start Page: 67End Page: 78Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24974Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.24974Citation Count: 527
- Deregulation of α-synuclein in Parkinson’s disease: Insight from epigenetic structure and transcriptional regulation of SNCA2017RESTRICTEDTitle: Deregulation of α-synuclein in Parkinson’s disease: Insight from epigenetic structure and transcriptional regulation of SNCAJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 154Issue #:Start Page: 21End Page: 36Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2017.04.004Best OA location URL: https://europepmc.org/articles/pmc5557282?pdf=renderCitation Count: 56
-
RESTRICTEDTitle: Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 83End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.05.001Citation Count: 7
- Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic mice2017RESTRICTEDTitle: Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic miceJournal Name: Neurobiology of Learning and MemoryPublisher: Elsevier BVVol: 142Issue #:Start Page: 182End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nlm.2017.05.001Best OA location URL: https://europepmc.org/articles/pmc5568523?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Improved Neuroimaging Atlas of the Dentate NucleusJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 16Issue #: 5-6Start Page: 951End Page: 956Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-017-0872-7Citation Count: 20
- Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease2017RESTRICTEDTitle: Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 55Issue #:Start Page: 78End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.012Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2017.03.012Citation Count: 46
-
RESTRICTEDTitle: Parkin and PINK1 functions in oxidative stress and neurodegenerationJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 133Issue #:Start Page: 51End Page: 59Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainresbull.2016.12.004Best OA location URL: https://europepmc.org/articles/pmc5718625?pdf=renderCitation Count: 119
-
RESTRICTEDTitle: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's diseaseJournal Name: Toxicology and Applied PharmacologyPublisher: Elsevier BVVol: 326Issue #:Start Page: 34End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004Best OA location URL: https://europepmc.org/articles/pmc5704913?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 36Issue #:Start Page: 20End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.02.003Citation Count: 33
-
RESTRICTEDTitle: Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 18End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.03.017Citation Count: 57
-
RESTRICTEDTitle: Unraveling the Biologic Basis for Domain-Specific Cognitive DeclineJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 7Start Page: 741End Page: 743Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.007Best OA location URL: https://europepmc.org/articles/pmc5870749?pdf=renderCitation Count: 0
- Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases2017RESTRICTEDTitle: Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset casesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 40End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.04.006Best OA location URL: http://www.prd-journal.com/article/S1353802017301360/pdfCitation Count: 14
- Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort2017RESTRICTEDTitle: Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa CohortJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 5Start Page: 755End Page: 762Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12511Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12511Citation Count: 30
- Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings2017RESTRICTEDTitle: Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling SettingsJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 26Issue #: 6Start Page: 1165End Page: 1172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0123-6Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s10897-017-0123-6Citation Count: 8
- Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s disease2017RESTRICTEDTitle: Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-04254-yBest OA location URL: https://doi.org/10.1038/s41598-017-04254-yCitation Count: 20
- The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease2017RESTRICTEDTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 75
-
RESTRICTEDTitle: Estimation of genetic risk function with covariates in the presence of missing genotypesJournal Name: Statistics in MedicinePublisher: WileyVol: 36Issue #: 22Start Page: 3533End Page: 3546Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/sim.7376Best OA location URL: https://europepmc.org/articles/pmc5583003?pdf=renderCitation Count: 4
- Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease2017RESTRICTEDTitle: Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 7Issue #: 7Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci7070074Best OA location URL: https://www.mdpi.com/2076-3425/7/7/74/pdf?version=1500945204Citation Count: 14
-
RESTRICTEDTitle: Latent Cognitive Phenotypes in De Novo Parkinson’s Disease: A Person-Centered ApproachJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 23Issue #: 7Start Page: 551End Page: 563Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1017/s1355617717000406Best OA location URL: https://europepmc.org/articles/pmc6435330?pdf=renderCitation Count: 8
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 12
-
RESTRICTEDTitle: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1432End Page: 1438Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27059Best OA location URL: https://europepmc.org/articles/pmc5656509?pdf=renderCitation Count: 130
- An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients2017RESTRICTEDTitle: An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease PatientsJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 34Issue #: 7Start Page: 1741End Page: 1752Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12325-017-0571-2Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs12325-017-0571-2.pdfCitation Count: 24
-
RESTRICTEDTitle: BCL-2 family: integrating stress responses at the ER to control cell demiseJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 24Issue #: 9Start Page: 1478End Page: 1487Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/cdd.2017.82Best OA location URL: https://www.nature.com/articles/cdd201782.pdfCitation Count: 186
- Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates2017RESTRICTEDTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 33
- Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity2017RESTRICTEDTitle: Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0021-5Best OA location URL: https://www.nature.com/articles/s41531-017-0021-5.pdfCitation Count: 33
-
RESTRICTEDTitle: Neuropathologic features of TOMM40 '523 variant on late‐life cognitive declineJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 12Start Page: 1380End Page: 1388Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2017.05.002Best OA location URL: https://europepmc.org/articles/pmc5723540?pdf=renderCitation Count: 14
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons2017RESTRICTEDTitle: Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal PersonsJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 317Issue #: 22Start Page: 2305End Page: 2305Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2017.6669Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2631529/jama_donohue_2017_oi_170051.pdfCitation Count: 318
- Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study2017RESTRICTEDTitle: Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation studyJournal Name: PLOS MedicinePublisher: Public Library of Science (PLoS)Vol: 14Issue #: 6Start Page: e1002314End Page: e1002314Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pmed.1002314Best OA location URL: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002314&type=printableCitation Count: 151
-
RESTRICTEDTitle: A Bayesian mathematical model of motor and cognitive outcomes in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 6Start Page: e0178982End Page: e0178982Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0178982Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0178982&type=printableCitation Count: 11
-
RESTRICTEDTitle: Mild cognitive impairment as a risk factor for Parkinson's disease dementiaJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 1056End Page: 1065Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27002Best OA location URL: https://escholarship.org/content/qt13d4s785/qt13d4s785.pdf?t=pijn6zCitation Count: 124
- Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology2017RESTRICTEDTitle: Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 7Start Page: 466End Page: 477Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.421Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.421Citation Count: 28
-
RESTRICTEDTitle: Role of LRRK2 in the regulation of dopamine receptor traffickingJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 6Start Page: e0179082End Page: e0179082Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0179082Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179082&type=printableCitation Count: 55
-
RESTRICTEDTitle: The missing, the short, and the long: Levodopa responses and dopamine actionsJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 1Start Page: 4End Page: 19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24961Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/137731/2/ana24961_am.pdfCitation Count: 34
-
RESTRICTEDTitle: A sensitive assay reveals structural requirements for α-synuclein fibril growthJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 292Issue #: 22Start Page: 9034End Page: 9050Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m116.767053Best OA location URL: http://www.jbc.org/article/S0021925820427061/pdfCitation Count: 22